Member Info for gtc1507

Also, this is great news too…

Further work on potential back-up antibodies may also be conducted in parallel, subject to agreeing further scopes of work and fees.

Allenby briefing note last year said they’d only earn $300k from this contract as it had been moving slower. RNS suggests they’ve received more than the full amount now for the existing contract which should be a good boost for 23/24. They’re also entitled to royalty and milestones from this contract.

Should boost the cash position for a while!

Id be cautious around that - their appointed broker has modelled in their most recent research note 250k per month. 55k a month is nothing

Welcome back Micho 😂

Https://x.com/share_talk/status/1749170698436702679?s=46

Good cautious counter!! May take some profits

Great to see how we move this week. Hourly, Daily and Weekly MA and technical indicators still suggesting strong buy potential so a way up till our next resistance point!

Awesome end to the week! Great potential for next week and beyond. If we have a nice RNS along the way then it’ll be party time! 🥳

Bid coming up now here’s round 2 coming

I can’t buy more than £500

200 day ma is 10.58. Golden cross coming maybe and a massive breakout further potentially….

Very interesting presentation. First time he did a dummies guide, clearly very passionate about the science. CEO also more than happy being paid in shares and buying them and is baffled by low market cap.

Larger proportion of larger buys to small scale sells though

It won’t be long until the good news comes!!

CEO was talking about very significant connections made at Antibody conference before Christmas in his presentation.

It’s nice it’s starting to tick up without the ramp and pump and dump brigade around too 😂

Agreed. Their CFO committed to update the market if there was a material change from their projections (which are no need to fundraise if they meet h2 targets which they were on track to do so in December) so in a way hopefully no news is good news.

I would anticipate we would get something this month hopefully anyway given they did commit to more frequent updates.

This is the acquisition . As of 2023 I believe it was publishers that fusion have royalty interests in 9 projects and a further financial interest in 4 which provide fixed milestone payments. If any or multiple of those are acquired or come to fruition then big payouts also, separately to the great prigesss being made on optimal and aimlab.

https://www.b3cnewswire.com/202401082504/calypso-enters-into-agreement-to-be-acquired-by-novartis.html

Expecting rally heading towards 8-9p

https://x.com/zakstraderscafe/status/1747561915759403438?s=46

Https://youtu.be/IAvbf90GgvQ?feature=shared

Where did you hear the November was cash neutral?